ArticleContemporary clinical trials2025

The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease.

Jesse C Christensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.